Management of chronic spinal cord dysfunction
- PMID: 25651225
- PMCID: PMC4325904
- DOI: 10.1212/01.CON.0000461092.86865.a4
Management of chronic spinal cord dysfunction
Abstract
Purpose of review: Both acute and chronic spinal cord disorders present multisystem management problems to the clinician. This article highlights key issues associated with chronic spinal cord dysfunction.
Recent findings: Advances in symptomatic management for chronic spinal cord dysfunction include use of botulinum toxin to manage detrusor hyperreflexia, pregabalin for management of neuropathic pain, and intensive locomotor training for improved walking ability in incomplete spinal cord injuries.
Summary: The care of spinal cord dysfunction has advanced significantly over the past 2 decades. Management and treatment of neurologic and non-neurologic complications of chronic myelopathies ensure that each patient will be able to maximize their functional independence and quality of life.
Figures
References
-
- National Spinal Cord Injury Statistical Center. Annual statistical reports: facts and figures. Birmingham, AL: University of Alabama at Birmingham; 2013.
-
- McDonald JW, Sadowsky C. Spinal-cord injury. Lancet 2002; 359 (9304): 417– 425 doi:10.1016/S0140-6736(02)07603-1. - PubMed
-
- Scivoletto G, Lapenna LM, Di Donna V, et al. Neoplastic myelopathies and traumatic spinal cord lesions: an Italian comparison of functional and neurological outcomes. Spinal Cord 2011; 49 (7): 799– 805 doi:10.1038/sc.2011.6. - PubMed
-
- Scivoletto G, Laurenza L, Mammone A, et al. Recovery following ischemic myelopathies and traumatic spinal cord lesions. Spinal Cord 2011; 49 (8): 897– 902 doi:10.1038/sc.2011.31. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous